Cargando…

Genetic and Molecular Mechanisms in Brugada Syndrome

Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Moras, Errol, Gandhi, Kruti, Narasimhan, Bharat, Brugada, Ramon, Brugada, Josep, Brugada, Pedro, Krittanawong, Chayakrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340412/
https://www.ncbi.nlm.nih.gov/pubmed/37443825
http://dx.doi.org/10.3390/cells12131791
_version_ 1785072073268264960
author Moras, Errol
Gandhi, Kruti
Narasimhan, Bharat
Brugada, Ramon
Brugada, Josep
Brugada, Pedro
Krittanawong, Chayakrit
author_facet Moras, Errol
Gandhi, Kruti
Narasimhan, Bharat
Brugada, Ramon
Brugada, Josep
Brugada, Pedro
Krittanawong, Chayakrit
author_sort Moras, Errol
collection PubMed
description Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, diagnosis, arrhythmia risk stratification, and management. The underlying electrophysiological mechanism of Brugada syndrome requires further investigation, with current theories focusing on abnormalities in repolarization, depolarization, and current-load match. The genetic basis of the syndrome is strong, with mutations found in genes encoding subunits of cardiac sodium, potassium, and calcium channels, as well as genes involved in channel trafficking and regulation. While the initial discovery of mutations in the SCN5A gene provided valuable insights, Brugada syndrome is now recognized as a multifactorial disease influenced by several loci and environmental factors, challenging the traditional autosomal dominant inheritance model. This comprehensive review aims to provide a current understanding of Brugada syndrome, focusing on its pathophysiology, genetic mechanisms, and novel models of risk stratification. Advancements in these areas hold the potential to facilitate earlier diagnosis, improve risk assessments, and enable more targeted therapeutic interventions.
format Online
Article
Text
id pubmed-10340412
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103404122023-07-14 Genetic and Molecular Mechanisms in Brugada Syndrome Moras, Errol Gandhi, Kruti Narasimhan, Bharat Brugada, Ramon Brugada, Josep Brugada, Pedro Krittanawong, Chayakrit Cells Review Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, diagnosis, arrhythmia risk stratification, and management. The underlying electrophysiological mechanism of Brugada syndrome requires further investigation, with current theories focusing on abnormalities in repolarization, depolarization, and current-load match. The genetic basis of the syndrome is strong, with mutations found in genes encoding subunits of cardiac sodium, potassium, and calcium channels, as well as genes involved in channel trafficking and regulation. While the initial discovery of mutations in the SCN5A gene provided valuable insights, Brugada syndrome is now recognized as a multifactorial disease influenced by several loci and environmental factors, challenging the traditional autosomal dominant inheritance model. This comprehensive review aims to provide a current understanding of Brugada syndrome, focusing on its pathophysiology, genetic mechanisms, and novel models of risk stratification. Advancements in these areas hold the potential to facilitate earlier diagnosis, improve risk assessments, and enable more targeted therapeutic interventions. MDPI 2023-07-05 /pmc/articles/PMC10340412/ /pubmed/37443825 http://dx.doi.org/10.3390/cells12131791 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Moras, Errol
Gandhi, Kruti
Narasimhan, Bharat
Brugada, Ramon
Brugada, Josep
Brugada, Pedro
Krittanawong, Chayakrit
Genetic and Molecular Mechanisms in Brugada Syndrome
title Genetic and Molecular Mechanisms in Brugada Syndrome
title_full Genetic and Molecular Mechanisms in Brugada Syndrome
title_fullStr Genetic and Molecular Mechanisms in Brugada Syndrome
title_full_unstemmed Genetic and Molecular Mechanisms in Brugada Syndrome
title_short Genetic and Molecular Mechanisms in Brugada Syndrome
title_sort genetic and molecular mechanisms in brugada syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340412/
https://www.ncbi.nlm.nih.gov/pubmed/37443825
http://dx.doi.org/10.3390/cells12131791
work_keys_str_mv AT moraserrol geneticandmolecularmechanismsinbrugadasyndrome
AT gandhikruti geneticandmolecularmechanismsinbrugadasyndrome
AT narasimhanbharat geneticandmolecularmechanismsinbrugadasyndrome
AT brugadaramon geneticandmolecularmechanismsinbrugadasyndrome
AT brugadajosep geneticandmolecularmechanismsinbrugadasyndrome
AT brugadapedro geneticandmolecularmechanismsinbrugadasyndrome
AT krittanawongchayakrit geneticandmolecularmechanismsinbrugadasyndrome